Current:Home > InvestNew COVID variant KP.3 climbs to 25%, now largest in CDC estimates -AssetLink
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
View
Date:2025-04-20 09:23:36
The new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease Control and Prevention estimated Friday, making it now the dominant strain of the virus nationwide.
KP.3's ascent comes as the CDC has tracked key metrics of spread from the virus now starting to trend up. Previous years have seen surges of the virus peak around August.
Data from CDC's wastewater surveillance has tracked levels of the virus starting to accelerate in the West. Emergency room visits for COVID-19 have inched up in recent weeks for all ages. COVID-19 infections are likely growing in 30 states and territories, the CDC now estimates.
"Very, very similar" to JN.1
KP.3 is now estimated to be outpacing the KP.2 variant, a so-called "FLiRT" strain that this week inched up to 22.5% of cases. KP.2 had risen to dominance in previous weeks, but its growth has now slowed.
Both KP.3 and KP.2 are "very, very similar" to the JN.1 variant that had dominated this past winter's wave of infections.
"When you look at KP.2 and KP.3, they're nearly identical to each other with really one difference between the two of them," Natalie Thornburg, the chief lab official at the CDC's Coronavirus and Other Respiratory Viruses Division, said Wednesday.
Thornburg was speaking at a Food and Drug Administration meeting debating what strains should be targeted by this fall's vaccines.
This difference is smaller than previous jumps in the virus, like when JN.1's parent – the highly mutated BA.2.86 variant – first emerged last year.
However, KP.2 and KP.3 are also not identical. Early data suggests KP.3's mutations might be better at evading immunity.
"JN.1 and KP.2-like viruses, they're really, really on top of each other. And KP.3 is very close, but not absolutely on top of it," Thornburg said.
Picking out new COVID-19 vaccines
KP.3's rise comes as the FDA said Friday that it had decided to call for shots this fall to be updated for the JN.1 variant that was dominant earlier this year, effectively turning down a newer formula aimed at the KP.2 variant.
"Yes, we always say we shouldn't be chasing strains, but we're paying an incredibly high premium for mRNA vaccines to be able to have the freshest vaccines," the FDA's Peter Marks had told the meeting.
Moderna had presented data from animal studies suggesting its KP.2-targeted shot offered similar protection against the latest variants, compared to a shot designed for JN.1. Pfizer's shot for KP.2 triggered better antibody responses for JN.1 variants, including KP.3.
"If this evolves further in the fall, will we regret not having been a little bit closer," Marks said.
But the FDA ultimately decided to pass on the KP.2 shots, after the agency's advisers worried it might not do a better job at broadening immunity for future strains compared to JN.1.
- In:
- Health
- Centers for Disease Control and Prevention
- Coronavirus Disease 2019
- COVID-19
- Coronavirus
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19.
TwitterveryGood! (3684)
Related
- Working Well: When holidays present rude customers, taking breaks and the high road preserve peace
- Reality show winner gets 10 years for enticing underage girl to cross state lines for sex
- Mass shooting shutters Arkansas town’s only grocery store — for now
- Landon Donovan has advice for Alex Morgan after Olympic roster heartbreak: 'It will pass'
- From family road trips to travel woes: Americans are navigating skyrocketing holiday costs
- Canadian wildfires released more carbon emissions than burning fossil fuels, study shows
- Guardians prospect homers in first MLB at-bat - and his former teammates go wild
- Why Simone Biles is 'close to unstoppable' as she just keeps getting better with age
- Small twin
- Elton John Reveals Why He'll Never Go on Tour Again
Ranking
- Rolling Loud 2024: Lineup, how to stream the world's largest hip hop music festival
- You’ll Be a Sucker for Nick Jonas and Daughter Malti's Adventurous Outing
- Marilyn Monroe’s former Los Angeles home declared a historic monument to save it from demolition
- 2 killed, 5 injured in gang-related shooting in Southern California’s high desert, authorities say
- Olympic men's basketball bracket: Results of the 5x5 tournament
- Delaware lawmakers approve a $1.1 billion capital budget for the fiscal year starting Monday
- Lupita Nyong'o says new 'Quiet Place' movie helped her cope with loss of Chadwick Boseman
- NHL mock draft 2024: Who's taken after Macklin Celebrini?
Recommendation
Most popular books of the week: See what topped USA TODAY's bestselling books list
US gymnastics Olympic trials: Frederick Richard slips by Brody Malone on first night
Minnesota judge is reprimanded for stripping voting rights from people with felonies
Former Arkansas legislator Joyce Elliott experiences stroke, undergoes surgery, her family says
Krispy Kreme offers a free dozen Grinch green doughnuts: When to get the deal
This couple has been together for 34 years. They're caring for the parents they worried about coming out to.
Willie Nelson pulls out of additional performance on Outlaw Music Festival Tour
Wall Street Journal reporter Evan Gershkovich goes on trial in Russia on espionage charges